OTC & Nutraceuticals China

China NAD+ Supplements Market Analysis, 2024–2034

China NAD+ Supplements Market Industry Trends and Forecast to 2034: Segmented by (Ingredient, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

China · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $47.3 Mn Estimated value
Estimate 2025 $53.2 Mn 8.6% of the global market
Projected 2034 $152.3 Mn 186.3% Adds $99.1 Mn over 9 forecast years
CAGR 2025–2034 12.4% Faster than 88% of 82 OTC & Nutraceuticals markets here
Key players 5 Companies profiled
  • China is 8.63% of the global market.
  • In APAC, the largest is China (this report) at $53.2 Mn.
  • Fastest growing: India at 14.2% a year.
  • China ranks 1st of 10 by size in APAC.

Market size projection

China

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$99.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
NAD+ Supplements Market market size by year, China
YearMarket sizeChange that yearSince 2025
2024 (estimate) $47.3 Mn — —
2025 (base) $53.2 Mn +$5.9 Mn —
2026 (forecast) $59.8 Mn +$6.6 Mn +12.4%
2027 (forecast) $67.2 Mn +$7.4 Mn +26.3%
2028 (forecast) $75.5 Mn +$8.3 Mn +42%
2029 (forecast) $84.9 Mn +$9.4 Mn +59.6%
2030 (forecast) $95.4 Mn +$10.5 Mn +79.4%
2031 (forecast) $107.3 Mn +$11.8 Mn +101.6%
2032 (forecast) $120.6 Mn +$13.3 Mn +126.7%
2033 (forecast) $135.5 Mn +$14.9 Mn +154.8%
2034 (forecast) $152.3 Mn +$16.8 Mn +186.3%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $616.1 Mn
  2. North America $274.6 Mn
  3. US $263.8 Mn
  4. Europe $121.8 Mn
  5. APAC $114.5 Mn
  6. Canada $53.5 Mn
  7. China (this report) $53.2 Mn
  8. Japan $41.0 Mn
  9. Latin America $27.6 Mn
  10. Middle East $26.6 Mn
  11. Germany $19.5 Mn
  12. France $17.5 Mn
  13. UK $17.1 Mn
  14. Brazil $14.5 Mn
  15. Ecuador $13.9 Mn
  16. Spain $12.7 Mn
  17. Italy $12.7 Mn
  18. India $13.0 Mn
  19. Saudi Arabia $12.0 Mn
  20. Mexico $10.6 Mn
  21. Africa $9.2 Mn
  22. Australia $8.1 Mn
  23. Russia $5.8 Mn
  24. New Zealand $5.3 Mn
  25. South Africa $4.4 Mn
  26. UAE $3.4 Mn
  27. Egypt $1.7 Mn
  28. Philippines $1.2 Mn
  29. Hong Kong $1.1 Mn
  30. Malaysia $0.9 Mn
  31. Singapore $0.9 Mn
  32. Thailand $0.7 Mn
  33. Kenya $0.5 Mn

The China NAD+ Supplements Market Analysis Executive Summary

NAD+ supplements, such as NMN and nicotinamide riboside, aim to raise levels of NAD+, a molecule linked to cell energy that falls with age.

Key segments of the NAD+ Supplements market include ingredient (Nicotinamide Riboside, NMN and NAD+ Direct) and form (Capsules, Powders and IV and Injections).

China NAD+ Supplements Market Dynamics

Market Growth Drivers

An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the NAD+ Supplements market. Older adults and their families are spending more on staying active and independent.

Opportunity

Preventive care, personalised plans based on biomarkers and home-based services give the NAD+ Supplements market room to grow, especially in fast-ageing countries in Asia and Europe.

Market Restraints

Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the NAD+ Supplements market.

Competitive Landscape for NAD+ Supplements Market in China

The NAD+ Supplements market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for NAD+ Supplements Market in China

Policy changes and Reimbursement scenario

Food and supplement rules, labelling and health-claim regulations govern NAD+ Supplements products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in China.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in NAD+ Supplements right now, from free public sources.

Latest research 1,091 papers since 2021 (worldwide)

  1. Systemic influences of dietary NAD(+) supplementation relevant to the search for ocular hypertensive therapies for glaucoma. Scientific reports, 2026
  2. Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome-Mediated Immunomodulation. Exploration (Beijing, China), 2026
  3. [Nicotinamide adenine dinucleotide and male reproductive health]. Zhonghua nan ke xue = National journal of andrology, 2025
  4. From NAD(+) elevation to clinical benefit: Tissue-specific regulation and translational barriers in aging and age-related disease. Pharmacological research, 2026
  5. The (amide-)N-methylnicotinamide is a microbe-derived NAD(+) precursor that drives gut stem cell renewal. Science advances, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

NAD+ Supplements in context

China compared

  • Health spending per person: 763 US$ per person (2023). World: 1,317 US$ per person (2023). 5th highest of the 15 countries we cover in APAC.[1]
  • Doctors: 3.11 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 3rd highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 14.9% of people (2025). World: 10.4% of people (2025). 6th highest of the 16 countries we cover in APAC.[3]

Questions, answered with public data

How many clinical trials on NAD+ Supplements are running in China?
2 studies are recruiting, active or about to start in China.[4]
How much research is published on NAD+ Supplements?
PubMed lists 1,091 papers added since January 2021 that match this market, worldwide.[5]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in China. Retrieved 12 Nov 2026.

[5] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about NAD+ Supplements in China? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Bone and Joint Health: Supplements for an Ageing Population1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence… Eye Health Supplements: Screens, Ageing and Vision2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a… Herbal Supplements: Quality, Safety and Trust170 of 194 WHO member states report use of traditional medicine. Herbal products are popular, but quality and…
Back to Catalogue
Keep exploring

Related OTC & Nutraceuticals reports in China

See all
Same topic, other categories

Related on geriatric and nutrition

See the topic